Envestnet Asset Management Inc. Boosts Stake in Ambev S.A. $ABEV

Envestnet Asset Management Inc. increased its holdings in shares of Ambev S.A. (NYSE:ABEV) by 6.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,388,972 shares of the company’s stock after acquiring an additional 210,112 shares during the period. Envestnet Asset Management Inc.’s holdings in Ambev were worth $7,557,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. CANADA LIFE ASSURANCE Co grew its stake in shares of Ambev by 74.8% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock worth $32,624,000 after purchasing an additional 5,740,155 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Ambev by 12.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company’s stock worth $80,410,000 after buying an additional 3,864,844 shares in the last quarter. Marshall Wace LLP grew its position in Ambev by 192.7% during the second quarter. Marshall Wace LLP now owns 4,208,299 shares of the company’s stock worth $10,142,000 after buying an additional 2,770,698 shares during the period. Bank of America Corp DE increased its holdings in Ambev by 9.9% in the second quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock valued at $66,288,000 after buying an additional 2,479,310 shares in the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC increased its holdings in Ambev by 12,937.7% in the second quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 2,385,900 shares of the company’s stock valued at $5,750,000 after buying an additional 2,367,600 shares in the last quarter. Institutional investors and hedge funds own 8.13% of the company’s stock.

Ambev Stock Performance

NYSE ABEV opened at $3.08 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.96 and a debt-to-equity ratio of 0.03. Ambev S.A. has a fifty-two week low of $1.87 and a fifty-two week high of $3.23. The business has a fifty day moving average of $2.70 and a 200-day moving average of $2.45. The stock has a market cap of $48.45 billion, a price-to-earnings ratio of 17.08, a price-to-earnings-growth ratio of 2.27 and a beta of 0.65.

Ambev (NYSE:ABEV) last posted its quarterly earnings data on Thursday, February 12th. The company reported $0.05 EPS for the quarter, hitting analysts’ consensus estimates of $0.05. The firm had revenue of $4.50 billion during the quarter, compared to analysts’ expectations of $4.28 billion. Ambev had a return on equity of 16.41% and a net margin of 17.75%. As a group, analysts predict that Ambev S.A. will post 0.18 earnings per share for the current fiscal year.

Ambev Dividend Announcement

The company also recently disclosed a special dividend, which was paid on Friday, January 9th. Investors of record on Monday, December 22nd were paid a dividend of $0.049 per share. The ex-dividend date of this dividend was Monday, December 22nd. This represents a dividend yield of 1,465.0%. Ambev’s dividend payout ratio is presently 183.33%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Weiss Ratings restated a “hold (c)” rating on shares of Ambev in a report on Monday, December 29th. Barclays boosted their target price on Ambev from $2.50 to $3.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Wall Street Zen upgraded Ambev from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Sanford C. Bernstein reiterated a “market perform” rating and issued a $2.88 price objective on shares of Ambev in a research report on Wednesday, November 26th. Six equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Ambev presently has a consensus rating of “Reduce” and a consensus price target of $2.69.

About Ambev

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.